Abstract Body

Background

Differentiated care for HIV increases viral suppression (VS). Incentives and home or smart locker delivery of antiretroviral therapy (ART) overcome barriers and could increase VS, esp. among young people. 

Methods

We conducted an adaptive randomized trial, the SMART ART Study, of optimized person-centered clinic services compared to home or smart locker ART services in South Africa. People living with HIV on ART who reported barriers to care were recruited and randomized to optimized clinic services with or without conditional lottery incentives. At six months, if not VS or barriers continued, participants were rerandomized to home or smart locker services or continued at the clinic. The primary outcome was month 18 VS, assessed using regression analysis, with prespecified subgroups for age and gender. 

Results

From Nov. 2021 – Apr. 2023, 874 participants were enrolled and randomized – 437 to the optimized clinic and 437 to the optimized clinic group with incentives. Overall, 435 (50%) participants were men, 103 (12%) were <30 years, 855 (98%) were on ART, and 794 (91%) were VS. At month 6, 801 participants (92%) were either not VS (116, 13%) or had barriers (778, 89%) and were rerandomized (2:1:1) to continue in the optimized clinic with or without lottery (N=405), smart locker (N=195), or home (N=201) group. Median follow-up was 86 weeks (IQR 77-100 weeks). Retention at exit was 93% (810/874). At month 18, the rate of VS in the clinic group was 89% (188/212) and with lottery was 88% (197/224); aRR=0.99, (CI: 0.93, 1.06). For participants <30 years, VS was 68% (26/38) in the clinic group and 85% (22/26) with lottery; aRR=1.22 (95% CI: 0.94, 1.58). After rerandomization, in the clinic group VS was 88% (341/388), 87% (160/183) in the smart locker, and 88% (169/191) in the home group; for smart locker vs. clinic aRR=1.00 (95% CI: 0.93, 1.06) and for home vs. clinic aRR=1.01 (95% CI: 0.95, 1.07). For participants <30 years, VS was 75% (41/55) in the clinic and 88% (23/26) in the smart locker group; aRR=1.24 (95% CI: 0.1.01, 1.52). For women, VS was 91% (186/205) in the clinic and 95% (92/97) in the home group; aRR=1.03 (95% CI: 0.97, 1.10, p=0.004 for NI).

Conclusions

Among adults living with HIV receiving optimized clinic services, including 6-month refills, VS was high (88%) and comparable to smart locker and home delivery. For participants <30 years, smart lockers increased VS. For women, home delivery may close gaps. Options for person-centered ART delivery may further increase VS.